FDA — authorised 22 April 1970
- Application: NDA016750
- Marketing authorisation holder: AMPHASTAR PHARMS INC
- Status: supplemented
FDA authorised Cortrosyn on 22 April 1970
Yes. FDA authorised it on 22 April 1970; FDA has authorised it.
AMPHASTAR PHARMS INC holds the US marketing authorisation.